Latest Breaking News On - Centre for target validation - Page 1 : comparemela.com

ICR and Merck renew strategic alliance in discovery and development of innovative new small-molecule cancer drugs The Institute of Cancer Research, London, and science and technology company Merck have renewed their strategic alliance in the discovery and development of new cancer drugs. Scientists in the.

United kingdomCity ofOlivia rossaneseCentre for cancer drug discoveryInstitute of cancer researchCentre for protein degradationHead of the division cancer therapeuticsCentre for target validationCancer research united kingdomCancer research united kingdom therapeutics unitCancer researchCancer drug discoverySouth londonTarget validationCancer therapeutics